Key facts
- It has raised $1.4M across 1 recorded rounds; the latest was Seed Round ($1.4M) in Jun 2024.
- Notable investors include Antler, Matter (Consulting Services (B2B)), Outlander VC, Unlock Capital (New York).
- Fidari has filed 2 Form Ds with the SEC since 2024, most recently Nov 2025 ($1.4M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Fidari
Funding rounds
1 roundsAbout Fidari
Operator of a healthcare platform intended to help cancer patients by enhancing access to good-quality care. The company offers personalized risk assessments along with care needs and preferences, at-home medical services, AI-integrated data analysis insights, targeted interventions, physical rehabilitation and pain management, and many more, enabling users to track their journey, log symptoms, engage in telehealth consultations and healthcare tools all within one convenient, secure platform resulting in reduced hospitalizations and the overall cost, promoting peace of mind.
- Sector
- Healthcare
- HQ
- Sante Fe, NM, United States
- Founded
- 2021
- Employees
- 10
- Website
- fidari.care/
- Ownership
- Privately Held (backing)
Fidari doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fidari shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fidari in its N-PORT filings yet. We sweep new filings monthly.